Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telithromycin Granules in Children with Infections
NCT00408135Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 2004
- Primary completion
- May 2005
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of telithromycin in respiratory tract infection (RTI), skin infection (SSTI), Otorhinolaryngologic Infection, tooth abscess, sponsored by Sanofi. Started Aug 2004; status: completed.
02
Drugs
telithromycin
03
Conditions
respiratory tract infection (RTI)skin infection (SSTI)Otorhinolaryngologic Infectiontooth abscess
Beyond the preview
Go deeper on NCT00408135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00408135.